Featured Content

AAP

What's News 5/18/2007

FDA Advisory Board Rejects Arthritis Drug Approval Gaithersburg, MD -- The FDA's Arthritis Drugs Advisory Committee voted overwhelmingly to reject approval of Merck's COX-2 inhibitor Arcoxia (etoricoxib).

Advertisement